Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21

  • Front Immunol. 2019 Apr 24;10:879. doi: 10.3389/fimmu.2019.00879.
SoonHo Kweon  1 Minh-Trang Thi Phan  2 Sejong Chun  3 HongBi Yu  4 Jinho Kim  4 Seokho Kim  5 Jaemin Lee  5 Alaa Kassim Ali  6 Seung-Hwan Lee  6 Sang-Ki Kim  7 Junsang Doh  8 Duck Cho  9  10  11
Affiliations
  • 1. School of Interdisciplinary Bioscience and Bioengineering (I-Bio), POSTECH, Pohang, South Korea.
  • 2. Department of Mechanical Engineering, POSTECH, Pohang, South Korea.
  • 3. Department of Laboratory Medicine, Chonnam National University, GwangJu, South Korea.
  • 4. Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea.
  • 5. Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea.
  • 6. Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
  • 7. Laboratory Animal Science, Department of Companion, Kongju National University, Yesan, South Korea.
  • 8. Department of Materials Science and Engineering, Seoul National University, Seoul, South Korea.
  • 9. Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • 10. Stem Cell and Regenerative Medicine Institute, Samsung Medical Center, Seoul, South Korea.
  • 11. Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, South Korea.
Abstract

Background: Natural Killer (NK) cell-based immunotherapy used to treat Cancer requires the adoptive transfer of a large number of activated NK cells. Here, we report a new effective method to expand human NK cells ex vivo using K562 cells genetically engineered (GE) to express OX40 Ligand (K562-OX40L) in combination with a short exposure to soluble IL-21. In addition, we describe a possible mechanism of the NK cell expansion through the OX40 receptor-OX40 ligand axis which is dependent on NK cell homotypic interaction. Methods: K562-OX40L cells were generated by lentiviral transduction and were used as feeder cells to expand and activate NK cells from PBMCs in the presence of IL-2/IL-15. Soluble IL-21 was also added in various concentrations only once at the beginning of the culture. NK cells were expanded for 4-5 weeks, and the purity, expansion rate, phenotype and function (cytotoxicity, antibody-dependent cell-mediated cytotoxicity (ADCC), cytokine production, CD107a degranulation) of these expanded NK cells were compared to those generated by using K562 feeder cells. Results: The culture of NK cells with K562-OX40L cells in combination with the transient exposure to IL-21 highly enhanced NK cell expansion to approximately 2,000-fold after 4 weeks of culture, compared to a 303-fold expansion using the conventional K562 cells. Mechanistically, the OX40-OX40L axis between the feeder cells and NK cells as well as the homotypic interaction between NK cells through the OX40-OX40L axis were both necessary for NK cell expansion. The short exposure of NK cells to IL-21 had a synergistic effect with OX40 signaling for NK cell expansion. Apart from their enhanced expansion, NK cells grown with K562-OX40L feeder cells were similar to those grown with conventional K562 cells in regard to the surface expression of various receptors, cytotoxicity, ADCC, cytokine secretion, and CD107 degranulation. Conclusion: Our data suggest that OX40 Ligand is a potent co-stimulant for the robust expansion of human NK cells and the homotypic NK cell interactions through the OX40-OX40L axis is a mechanism of NK cell expansion.

Keywords
IL-21; K562; OX40 ligand; expansion; natural killer cells.
Products